Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

NCT06919341 is registered in ClinicalTrials.gov with Fundación Española de Hematología y Hemoterapía as lead sponsor.

NCT NCT06919341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06919341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
Lead sponsor
Fundación Española de Hematología y Hemoterapía
Phase
Observational
Overall status
Recruiting
Start date
September 27, 2024
Completion date
September 30, 2034
Enrollment
1,000 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

itp - immune thrombocytopenia, primary immune thrombocytopenia (itp)